Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1982 Jan;47(1):147–154.

Impaired primary in-vitro antibody response in progressive systemic sclerosis patients: rôle of suppressor monocytes.

P Segond, D Salliere, P Galanaud, R M Desmottes, P Massias, J N Fiessinger
PMCID: PMC1536373  PMID: 6212171

Abstract

The primary in-vitro antibody response developed by peripheral blood mononuclear cells (PBM) towards trinitrophenyl coupled to polyacrylamide beads (TNP-PAA) was evaluated in 17 untreated patients with progressive systemic sclerosis (PSS). This response was markedly depressed as compared with that of 19 control patients and 28 normal subjects. In eight PSS patients and eight normal controls the anti-TNP response was measured before, and after, a PBM filtration on nylon wool columns. This procedure dramatically reduced the proportion of monocytes identified as mononuclear cells staining positively for peroxidases, and restored the response of PSS PBM to the level observed in normal PBM. In four experiments, plastic-adherent cells from either normal subjects of PSS patients were added to autologous nylon-passed PBM. This did not modify the response from normal PBM but inhibited the response of PSS PBM. The inhibitory effect of PSS plastic-adherent cells was insensitive to a 2,000 R X-ray irradiation. These results strongly suggest that the impaired in-vitro antibody response observed in PSS can be attributed to a suppressor monocyte. The concanavalin-A-induced suppressor cells of the antibody response were assayed in PSS. They exerted a suppressive effect to the same extent as in controls.

Full text

PDF
147

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cooper S. M., Harding B., Mirick G. R., Schneider J., Quismorio F. P., Friou G. J. Selective decrease in antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus and progressive systemic sclerosis. Clin Exp Immunol. 1978 Nov;34(2):235–240. [PMC free article] [PubMed] [Google Scholar]
  2. Delfraissy J. F., Galanaud P., Dormont J., Wallon C. Primary in vitro antibody response from human peripheral blood lymphocytes. J Immunol. 1977 Feb;118(2):630–635. [PubMed] [Google Scholar]
  3. Delfraissy J. F., Galanaud P., Dormont J., Wallon C. Primary in vitro antibody response of human peripheral blood lymphocytes: role of phagocytic mononuclear cells. J Immunol. 1978 Apr;120(4):1283–1288. [PubMed] [Google Scholar]
  4. Delfraissy J. F., Segond P., Galanaud P., Wallon C., Massias P., Dormont J. Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function. J Clin Invest. 1980 Jul;66(1):141–148. doi: 10.1172/JCI109827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Galanaud P., Crevon M. C., Delfraissy J. F., Segond P., Wallon C., Dormont J. Regulation of the primary in vitro antibody response in human peripheral blood lymphocytes: different effects of mitogen-induced and spontaneous T suppressor cells. Clin Exp Immunol. 1979 Oct;38(1):106–115. [PMC free article] [PubMed] [Google Scholar]
  6. Galanaud P. In vitro antibody response to trinitrophenyl-polyacrylamide beads. Immunol Rev. 1979;45:141–161. doi: 10.1111/j.1600-065x.1979.tb00276.x. [DOI] [PubMed] [Google Scholar]
  7. Gmelig-Meyling F., Waldmann T. A. Human B cell activation in vitro: augmentation and suppression by monocytes of the immunoglobulin production induced by various B cell stimulants. J Immunol. 1981 Feb;126(2):529–537. [PubMed] [Google Scholar]
  8. Goodwin J. S., Messner R. P., Bankhurst A. D., Peake G. T., Saiki J. H., Williams R. C., Jr Prostaglandin-producing suppressor cells in Hodgkin's disease. N Engl J Med. 1977 Nov 3;297(18):963–968. doi: 10.1056/NEJM197711032971802. [DOI] [PubMed] [Google Scholar]
  9. Goodwin J. S., Webb D. R. Regulation of the immune response by prostaglandins. Clin Immunol Immunopathol. 1980 Jan;15(1):106–122. doi: 10.1016/0090-1229(80)90024-0. [DOI] [PubMed] [Google Scholar]
  10. Gupta S., Malaviya A. N., Rajagopalan P., Good R. A. Subpopulations of human T lymphocytes. IX. Imbalance of T cell subpopulations in patients with progressive systemic sclerosis. Clin Exp Immunol. 1979 Nov;38(2):342–347. [PMC free article] [PubMed] [Google Scholar]
  11. Hillion D., Galanaud P., Preud'homme J. L., Niaudet P., Wallon C., Crevon M. C. Immunoglobulin-producing cells in cultured human peripheral blood lymphocytes. Modulation by accessory cells and enhancing effect of polyacrylamide beads. Clin Immunol Immunopathol. 1980 Jun;16(2):192–201. doi: 10.1016/0090-1229(80)90203-2. [DOI] [PubMed] [Google Scholar]
  12. Horwitz D. A., Garrett M. A. Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Clin Exp Immunol. 1977 Jan;27(1):92–99. [PMC free article] [PubMed] [Google Scholar]
  13. Hughes P., Holt S., Rowell N. R., Allonby I. D., Janis K., Dodd J. K. The relationship of defective cell-mediated immunity to visceral disease in systemic sclerosis. Clin Exp Immunol. 1977 May;28(2):233–240. [PMC free article] [PubMed] [Google Scholar]
  14. Kallenberg C. G., Van der Voort-Beelen J. M., D'Amaro J., The T. H. Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response. Clin Exp Immunol. 1981 Mar;43(3):478–485. [PMC free article] [PubMed] [Google Scholar]
  15. Katz P., Fauci A. S. Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis. Clin Exp Immunol. 1978 Jun;32(3):554–562. [PMC free article] [PubMed] [Google Scholar]
  16. Luzzati A. L., Heinzer I., Hengartner H., Schreier M. H. Induction of plaque-forming cells in human blood lymphocytes cultured in the presence of antigen and Epstein-Barr virus: a study with normal donors and infectious mononucleosis patients. Clin Exp Immunol. 1979 Mar;35(3):405–412. [PMC free article] [PubMed] [Google Scholar]
  17. Markenson J. A., Morgan J. W., Lockshin M. D., Joachim C., Winfield J. B. Responses of fractionated cells from patients with systemic lupus erythematosus and normals to plant mitogen: evidence for a suppressor population of monocytes. Proc Soc Exp Biol Med. 1978 May;158(1):5–9. doi: 10.3181/00379727-158-40127. [DOI] [PubMed] [Google Scholar]
  18. Montazeri G., Chiorazzi N., Fu S. M., Kunkel H. G. Regulatory role of circulating monocytes in the differentiative and proliferative responses of human B lymphocytes. Clin Immunol Immunopathol. 1980 May;16(1):1–10. doi: 10.1016/0090-1229(80)90160-9. [DOI] [PubMed] [Google Scholar]
  19. Niwa Y., Kanoh T. Immune deficiency states and immune imbalance in systemic lupus erythematosus and other autoimmune diseases. Clin Immunol Immunopathol. 1979 Mar;12(3):289–300. doi: 10.1016/0090-1229(79)90032-1. [DOI] [PubMed] [Google Scholar]
  20. Preud'homme J. L., Flandrin G. Identification by peroxidase staining of monocytes in surface immunofluorescence tests. J Immunol. 1974 Nov;113(5):1650–1653. [PubMed] [Google Scholar]
  21. Segond P., Delfraissy J. F., Galanaud P., Wallon C., Massias P., Dormont J. Depressed primary in vitro antibody response in rheumatoid arthritis. Clin Exp Immunol. 1979 Aug;37(2):196–204. [PMC free article] [PubMed] [Google Scholar]
  22. Velayos E. E., Masi A. T., Stevens M. B., Shulman L. E. The 'CREST' syndrome. Comparison with systemic sclerosis (scleroderma). Arch Intern Med. 1979 Nov;139(11):1240–1244. doi: 10.1001/archinte.139.11.1240. [DOI] [PubMed] [Google Scholar]
  23. Wright J. K., Hughes P., Rowell N. R., Sneddon I. B. Antibody-dependent and phytohaemagglutinin-induced lymphocyte cytotoxicity in systemic sclerosis. Clin Exp Immunol. 1979 Apr;36(1):175–182. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES